Literature DB >> 33462414

Roles and mechanisms of BAP1 deubiquitinase in tumor suppression.

Louis Masclef1, Oumaima Ahmed1, Benjamin Estavoyer1, Bruno Larrivée2,3, Nathalie Labrecque4,5, Anastasia Nijnik6,7, El Bachir Affar8,9.   

Abstract

The BAP1 gene has emerged as a major tumor suppressor mutated with various frequencies in numerous human malignancies, including uveal melanoma, malignant pleural mesothelioma, clear cell renal cell carcinoma, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and thymic epithelial tumors. BAP1 mutations are also observed at low frequency in other malignancies including breast, colorectal, pancreatic, and bladder cancers. BAP1 germline mutations are associated with high incidence of mesothelioma, uveal melanoma, and other cancers, defining the "BAP1 cancer syndrome." Interestingly, germline BAP1 mutations constitute an important paradigm for gene-environment interactions, as loss of BAP1 predisposes to carcinogen-induced tumorigenesis. Inactivating mutations of BAP1 are also identified in sporadic cancers, denoting the importance of this gene for normal tissue homeostasis and tumor suppression, although some oncogenic properties have also been attributed to BAP1. BAP1 belongs to the deubiquitinase superfamily of enzymes, which are responsible for the maturation and turnover of ubiquitin as well as the reversal of substrate ubiquitination, thus regulating ubiquitin signaling. BAP1 is predominantly nuclear and interacts with several chromatin-associated factors, assembling multi-protein complexes with mutually exclusive partners. BAP1 exerts its function through highly regulated deubiquitination of its substrates. As such, BAP1 orchestrates chromatin-associated processes including gene expression, DNA replication, and DNA repair. BAP1 also exerts cytoplasmic functions, notably in regulating Ca2+ signaling at the endoplasmic reticulum. This DUB is also subjected to multiple post-translational modifications, notably phosphorylation and ubiquitination, indicating that several signaling pathways tightly regulate its function. Recent progress indicated that BAP1 plays essential roles in multiple cellular processes including cell proliferation and differentiation, cell metabolism, as well as cell survival and death. In this review, we summarize the biological and molecular functions of BAP1 and explain how the inactivation of this DUB might cause human cancers. We also highlight some of the unresolved questions and suggest potential new directions.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33462414      PMCID: PMC7862696          DOI: 10.1038/s41418-020-00709-4

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   12.067


  148 in total

1.  BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.

Authors:  D E Jensen; M Proctor; S T Marquis; H P Gardner; S I Ha; L A Chodosh; A M Ishov; N Tommerup; H Vissing; Y Sekido; J Minna; A Borodovsky; D C Schultz; K D Wilkinson; G G Maul; N Barlev; S L Berger; G C Prendergast; F J Rauscher
Journal:  Oncogene       Date:  1998-03-05       Impact factor: 9.867

2.  Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB.

Authors:  Johanna C Scheuermann; Andrés Gaytán de Ayala Alonso; Katarzyna Oktaba; Nga Ly-Hartig; Robert K McGinty; Sven Fraterman; Matthias Wilm; Tom W Muir; Jürg Müller
Journal:  Nature       Date:  2010-05-02       Impact factor: 49.962

3.  BRCA1-associated protein 1 (BAP1) deubiquitinase antagonizes the ubiquitin-mediated activation of FoxK2 target genes.

Authors:  Yuki Okino; Yuka Machida; Sarah Frankland-Searby; Yuichi J Machida
Journal:  J Biol Chem       Date:  2014-12-01       Impact factor: 5.157

4.  The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression.

Authors:  Helen Yu; Nazar Mashtalir; Salima Daou; Ian Hammond-Martel; Julie Ross; Guangchao Sui; Gerald W Hart; Frank J Rauscher; Elliot Drobetsky; Eric Milot; Yang Shi; El Bachir Affar
Journal:  Mol Cell Biol       Date:  2010-08-30       Impact factor: 4.272

5.  Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1.

Authors:  Shahram Misaghi; Søren Ottosen; Anita Izrael-Tomasevic; David Arnott; Mohamed Lamkanfi; James Lee; Jinfeng Liu; Karen O'Rourke; Vishva M Dixit; Angus C Wilson
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

6.  Defining the human deubiquitinating enzyme interaction landscape.

Authors:  Mathew E Sowa; Eric J Bennett; Steven P Gygi; J Wade Harper
Journal:  Cell       Date:  2009-07-16       Impact factor: 41.582

7.  The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1.

Authors:  Yuichi J Machida; Yuka Machida; Ajay A Vashisht; James A Wohlschlegel; Anindya Dutta
Journal:  J Biol Chem       Date:  2009-10-08       Impact factor: 5.157

8.  The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer.

Authors:  Salima Daou; Ian Hammond-Martel; Nazar Mashtalir; Haithem Barbour; Jessica Gagnon; Nicholas V G Iannantuono; Nadine Sen Nkwe; Alena Motorina; Helen Pak; Helen Yu; Hugo Wurtele; Eric Milot; Frédérick A Mallette; Michele Carbone; El Bachir Affar
Journal:  J Biol Chem       Date:  2015-09-28       Impact factor: 5.157

9.  Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O.

Authors:  Nazar Mashtalir; Salima Daou; Haithem Barbour; Nadine N Sen; Jessica Gagnon; Ian Hammond-Martel; Haider H Dar; Marc Therrien; El Bachir Affar
Journal:  Mol Cell       Date:  2014-04-03       Impact factor: 17.970

10.  Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1.

Authors:  Salima Daou; Haithem Barbour; Oumaima Ahmed; Louis Masclef; Caroline Baril; Nadine Sen Nkwe; Daméhan Tchelougou; Maxime Uriarte; Eric Bonneil; Derek Ceccarelli; Nazar Mashtalir; Mika Tanji; Jean-Yves Masson; Pierre Thibault; Frank Sicheri; Haining Yang; Michele Carbone; Marc Therrien; El Bachir Affar
Journal:  Nat Commun       Date:  2018-10-22       Impact factor: 14.919

View more
  18 in total

1.  BAP1 promotes the repair of UV-induced DNA damage via PARP1-mediated recruitment to damage sites and control of activity and stability.

Authors:  Shin-Ai Lee; Daye Lee; Minhwa Kang; Sora Kim; Su-Jung Kwon; Han-Sae Lee; Hye-Ran Seo; Prashant Kaushal; Nam Soo Lee; Hongtae Kim; Cheolju Lee; Jongbum Kwon
Journal:  Cell Death Differ       Date:  2022-05-30       Impact factor: 15.828

2.  BAP1 shapes the bone marrow niche for lymphopoiesis by fine-tuning epigenetic profiles in endosteal mesenchymal stromal cells.

Authors:  Jinguk Jeong; Inkyung Jung; Ji-Hoon Kim; Shin Jeon; Do Young Hyeon; Hyungyu Min; Byeonggeun Kang; Jinwoo Nah; Daehee Hwang; Soo-Jong Um; Myunggon Ko; Rho Hyun Seong
Journal:  Cell Death Differ       Date:  2022-04-26       Impact factor: 15.828

Review 3.  Deubiquitinases in cell death and inflammation.

Authors:  Kim Newton; Alexander D Gitlin
Journal:  Biochem J       Date:  2022-05-27       Impact factor: 3.766

Review 4.  Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations.

Authors:  Michele Carbone; Harvey I Pass; Guntulu Ak; H Richard Alexander; Paul Baas; Francine Baumann; Andrew M Blakely; Raphael Bueno; Aleksandra Bzura; Giuseppe Cardillo; Jane E Churpek; Irma Dianzani; Assunta De Rienzo; Mitsuru Emi; Salih Emri; Emanuela Felley-Bosco; Dean A Fennell; Raja M Flores; Federica Grosso; Nicholas K Hayward; Mary Hesdorffer; Chuong D Hoang; Peter A Johansson; Hedy L Kindler; Muaiad Kittaneh; Thomas Krausz; Aaron Mansfield; Muzaffer Metintas; Michael Minaai; Luciano Mutti; Maartje Nielsen; Kenneth O'Byrne; Isabelle Opitz; Sandra Pastorino; Francesca Pentimalli; Marc de Perrot; Antonia Pritchard; Robert Taylor Ripley; Bruce Robinson; Valerie Rusch; Emanuela Taioli; Yasutaka Takinishi; Mika Tanji; Anne S Tsao; A Murat Tuncer; Sebastian Walpole; Andrea Wolf; Haining Yang; Yoshie Yoshikawa; Alicia Zolondick; David S Schrump; Raffit Hassan
Journal:  J Thorac Oncol       Date:  2022-04-21       Impact factor: 20.121

5.  Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma.

Authors:  Qi Wang; Hanmin Tang; Xuehui Luo; Jie Chen; Xinyue Zhang; Xinyue Li; Yuesen Li; Yuetong Chen; Yungang Xu; Suxia Han
Journal:  Front Immunol       Date:  2022-05-24       Impact factor: 8.786

6.  Rare germline heterozygous missense variants in BRCA1-associated protein 1, BAP1, cause a syndromic neurodevelopmental disorder.

Authors:  Sébastien Küry; Frédéric Ebstein; Alice Mollé; Thomas Besnard; Ming-Kang Lee; Virginie Vignard; Tiphaine Hery; Mathilde Nizon; Grazia M S Mancini; Jacques C Giltay; Benjamin Cogné; Kirsty McWalter; Wallid Deb; Hagar Mor-Shaked; Hong Li; Rhonda E Schnur; Ingrid M Wentzensen; Anne-Sophie Denommé-Pichon; Cynthia Fourgeux; Frans W Verheijen; Eva Faurie; Rachel Schot; Cathy A Stevens; Daphne J Smits; Eileen Barr; Ruth Sheffer; Jonathan A Bernstein; Chandler L Stimach; Eliana Kovitch; Vandana Shashi; Kelly Schoch; Whitney Smith; Richard H van Jaarsveld; Anna C E Hurst; Kirstin Smith; Evan H Baugh; Suzanne G Bohm; Emílie Vyhnálková; Lukáš Ryba; Capucine Delnatte; Juanita Neira; Dominique Bonneau; Annick Toutain; Jill A Rosenfeld; Séverine Audebert-Bellanger; Brigitte Gilbert-Dussardier; Sylvie Odent; Frédéric Laumonnier; Seth I Berger; Ann C M Smith; Franck Bourdeaut; Marc-Henri Stern; Richard Redon; Elke Krüger; Raphaël Margueron; Stéphane Bézieau; Jeremie Poschmann; Bertrand Isidor
Journal:  Am J Hum Genet       Date:  2022-01-19       Impact factor: 11.043

Review 7.  Serine and one-carbon metabolisms bring new therapeutic venues in prostate cancer.

Authors:  Carlo Ganini; Ivano Amelio; Riccardo Bertolo; Eleonora Candi; Angela Cappello; Chiara Cipriani; Alessandro Mauriello; Carla Marani; Gerry Melino; Manuela Montanaro; Maria Emanuela Natale; Giuseppe Tisone; Yufang Shi; Ying Wang; Pierluigi Bove
Journal:  Discov Oncol       Date:  2021-10-27

8.  Unusual Histology in Mesothelioma: A Report of Two Cases with a Brief Review.

Authors:  Francesca Bono; Stefano Ceola; Carlo Beretta; Marta Jaconi
Journal:  Diagnostics (Basel)       Date:  2022-02-01

Review 9.  Genetic Basis and Molecular Mechanisms of Uveal Melanoma Metastasis: A Focus on Prognosis.

Authors:  Carla Enrica Gallenga; Elena Franco; Ginevra Giovanna Adamo; Sara Silvia Violanti; Paolo Tassinari; Mauro Tognon; Paolo Perri
Journal:  Front Oncol       Date:  2022-04-11       Impact factor: 5.738

Review 10.  When the Diagnosis of Mesothelioma Challenges Textbooks and Guidelines.

Authors:  Giulio Rossi; Fabio Davoli; Venerino Poletti; Alberto Cavazza; Filippo Lococo
Journal:  J Clin Med       Date:  2021-05-30       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.